Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-24-249236
Filing Date
2024-11-01
Accepted
2024-11-01 08:02:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 POS AM d865587dposam.htm POS AM 18164
  Complete submission text file 0001193125-24-249236.txt   19214
Mailing Address 75 STATE STREET SUITE 100 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 100 BOSTON MA 02109 617-229-6499
Finch Therapeutics Group, Inc. (Filer) CIK: 0001733257 (see all company filings)

IRS No.: 823433558 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-265173 | Film No.: 241417118
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)